Circadian Gene Circuitry Predicts Hyperactive Behavior in a Mood Disorder Mouse Model

Cell Reports

Volumn 14, Issue 12, 2016, Pages 2784-2796

  Hagihara, Hideo ^a,b   Horikawa, Tomoyasu ^c   Nakamura, Hironori K ^a,b   Umemori, Juzoh ^a,b   Shoji, Hirotaka ^a,b   Kamitani, Yukiyasu ^c,d   Miyakawa, Tsuyoshi ^a,b,e  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c ADVANCED TELECOMMUNICATIONS RESEARCH INSTITUTE INTERNATIONAL   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; DNA BINDING PROTEIN; HIVEP2 PROTEIN, MOUSE; TRANSCRIPTOME;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOINFORMATICS; CIRCADIAN GENE; CONTROLLED STUDY; DENTATE GYRUS; FORCED SWIM TEST; GENE; GENE EXPRESSION; KNOCKOUT MOUSE; LOCOMOTION; MALE; MICROARRAY ANALYSIS; MOOD DISORDER; MOUSE; NONHUMAN; OPEN FIELD TEST; OSCILLATION; PRIORITY JOURNAL; WILD TYPE; ANIMAL; ANXIETY; CIRCADIAN RHYTHM; DEFICIENCY; DEPRESSION; DISEASE MODEL; GENETICS; HETEROZYGOTE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANXIETY; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CIRCADIAN RHYTHM; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DENTATE GYRUS; DEPRESSION; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; HETEROZYGOTE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MICE; MICE, KNOCKOUT; MOOD DISORDERS; TRANSCRIPTOME;

EID: 84963894596     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.02.067     Document Type: Article

References (83)

1. Ament S.A., Szelinger S., Glusman G., Ashworth J., Hou L., Akula N., Shekhtman T., Badner J.A., Brunkow M.E., Mauldin D.E., et al. Rare variants in neuronal excitability genes influence risk for bipolar disorder. Proc. Natl. Acad. Sci. USA 2015, 112:3576-3581. Bipolar Genome Study.
2. Belmaker R.H. Bipolar disorder. N. Engl. J. Med. 2004, 351:476-486.
3. Bender A.T., Beavo J.A. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol. Rev. 2006, 58:488-520.
4. Bertolino A., Frye M., Callicott J.H., Mattay V.S., Rakow R., Shelton-Repella J., Post R., Weinberger D.R. Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biol. Psychiatry 2003, 53:906-913.
5. Brown E.S., Rush A.J., McEwen B.S. Hippocampal remodeling and damage by corticosteroids: implications for mood disorders. Neuropsychopharmacology 1999, 21:474-484.
6. Bryson R.W., Martin D.F. 17-Ketosteroid excretion in a case of manic-depressive psychosis. Lancet 1954, 267:365-367.
7. Calabrese J.R., Fatemi S.H., Woyshville M.J. Antidepressant effects of lamotrigine in rapid cycling bipolar disorder. Am. J. Psychiatry 1996, 153:1236.
8. Campbell S., Marriott M., Nahmias C., MacQueen G.M. Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am. J. Psychiatry 2004, 161:598-607.
9. Chemello F., Bean C., Cancellara P., Laveder P., Reggiani C., Lanfranchi G. Microgenomic analysis in skeletal muscle: expression signatures of individual fast and slow myofibers. PLoS ONE 2011, 6:e16807.
10. Chen C.-H., Suckling J., Ooi C., Jacob R., Lupson V., Bullmore E.T., Lennox B.R. A longitudinal fMRI study of the manic and euthymic states of bipolar disorder. Bipolar Disord. 2010, 12:344-347.
11. Coyle J.T., Duman R.S. Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 2003, 38:157-160.
12. David D.J., Wang J., Samuels B.A., Rainer Q., David I., Gardier A.M., Hen R. Implications of the functional integration of adult-born hippocampal neurons in anxiety-depression disorders. Neuroscientist 2010, 16:578-591.
13. Dopico X.C., Evangelou M., Ferreira R.C., Guo H., Pekalski M.L., Smyth D.J., Cooper N., Burren O.S., Fulford A.J., Hennig B.J., et al. Widespread seasonal gene expression reveals annual differences in human immunity and physiology. Nat. Commun. 2015, 6:7000.
14. Duman R.S., Nakagawa S., Malberg J. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology 2001, 25:836-844.
15. Eastwood M.R., Whitton J.L., Kramer P.M., Peter A.M. Infradian rhythms. A comparison of affective disorders and normal persons. Arch. Gen. Psychiatry 1985, 42:295-299.
16. Eckel-Mahan K.L., Phan T., Han S., Wang H., Chan G.C.K., Scheiner Z.S., Storm D.R. Circadian oscillation of hippocampal MAPK activity and cAmp: implications for memory persistence. Nat. Neurosci. 2008, 11:1074-1082.
17. Einat H., Yuan P., Gould T.D., Li J., Du J., Zhang L., Manji H.K., Chen G. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J. Neurosci. 2003, 23:7311-7316.
18. Femenía T., Gómez-Galán M., Lindskog M., Magara S. Dysfunctional hippocampal activity affects emotion and cognition in mood disorders. Brain Res. 2012, 1476:58-70.
19. Ginty D.D., Kornhauser J.M., Thompson M.A., Bading H., Mayo K.E., Takahashi J.S., Greenberg M.E. Regulation of CREB phosphorylation in the suprachiasmatic nucleus by light and a circadian clock. Science 1993, 260:238-241.
20. Hagihara H., Toyama K., Yamasaki N., Miyakawa T. Dissection of hippocampal dentate gyrus from adult mouse. J. Vis. Exp. 2009, 33:1543.
21. Hagihara H., Takao K., Walton N.M., Matsumoto M., Miyakawa T. Immature dentate gyrus: an endophenotype of neuropsychiatric disorders. Neural Plast. 2013, 2013:318596.
22. Hagihara H., Ohira K., Takao K., Miyakawa T. Transcriptomic evidence for immaturity of the prefrontal cortex in patients with schizophrenia. Mol. Brain 2014, 7:41.
23. Harrisingh M.C., Nitabach M.N. Circadian rhythms. Integrating circadian timekeeping with cellular physiology. Science 2008, 320:879-880.
24. Hattori S., Hagihara H., Ohira K., Aoki I., Saga T., Suhara T., Higuchi M., Miyakawa T. In vivo evaluation of cellular activity in αCaMKII heterozygous knockout mice using manganese-enhanced magnetic resonance imaging (MEMRI). Front. Integr. Nuerosci. 2013, 7:76.
25. Hesketh K.R., McMinn A.M., Ekelund U., Sharp S.J., Collings P.J., Harvey N.C., Godfrey K.M., Inskip H.M., Cooper C., van Sluijs E.M. Objectively measured physical activity in four-year-old British children: a cross-sectional analysis of activity patterns segmented across the day. Int. J. Behav. Nutr. Phys. Act. 2014, 11:1.
26. Hinckley M., Vaccari S., Horner K., Chen R., Conti M. The G-protein-coupled receptors GPR3 and GPR12 are involved in cAMP signaling and maintenance of meiotic arrest in rodent oocytes. Dev. Biol. 2005, 287:249-261.
27. Horikawa T., Tamaki M., Miyawaki Y., Kamitani Y. Neural decoding of visual imagery during sleep. Science 2013, 340:639-642.
28. Hua P., Liu W., Kuo S.-H., Zhao Y., Chen L., Zhang N., Wang C., Guo S., Wang L., Xiao H., et al. Association of Tef polymorphism with depression in Parkinson disease. Mov. Disord. 2012, 27:1694-1697.
29. Hua P., Liu W., Chen D., Zhao Y., Chen L., Zhang N., Wang C., Guo S., Wang L., Xiao H., Kuo S.H. Cry1 and Tef gene polymorphisms are associated with major depressive disorder in the Chinese population. J. Affect. Disord. 2014, 157:100-103.
30. Jackson A., Cavanagh J., Scott J. A systematic review of manic and depressive prodromes. J. Affect. Disord. 2003, 74:209-217.
31. Kato T. Molecular genetics of bipolar disorder and depression. Psychiatry Clin. Neurosci. 2007, 61:3-19.
32. Kittleson M.M., Hare J.M. Molecular signature analysis: using the myocardial transcriptome as a biomarker in cardiovascular disease. Trends Cardiovasc. Med. 2005, 15:130-138.
33. Kondratov R.V., Chernov M.V., Kondratova A.A., Gorbacheva V.Y., Gudkov A.V., Antoch M.P. BMAL1-dependent circadian oscillation of nuclear CLOCK: posttranslational events induced by dimerization of transcriptional activators of the mammalian clock system. Genes Dev. 2003, 17:1921-1932.
34. Krishnan V., Nestler E.J. The molecular neurobiology of depression. Nature 2008, 455:894-902.
35. Kubota M., Kasahara T., Iwamoto K., Komori A., Ishiwata M., Miyauchi T., Kato T. Therapeutic implications of down-regulation of cyclophilin D in bipolar disorder. Int. J. Neuropsychopharmacol. 2010, 13:1355-1368.
36. Kusumakar V., Yatham L.N. Lamotrigine treatment of rapid cycling bipolar disorder. Am. J. Psychiatry 1997, 154:1171-1172.
37. Lanz T.A., Guilmette E., Gosink M.M., Fischer J.E., Fitzgerald L.W., Stephenson D.T., Pletcher M.T. Transcriptomic analysis of genetically defined autism candidate genes reveals common mechanisms of action. Mol. Autism 2013, 4:45.
38. Laposky A., Easton A., Dugovic C., Walisser J., Bradfield C., Turek F. Deletion of the mammalian circadian clock gene BMAL1/Mop3 alters baseline sleep architecture and the response to sleep deprivation. Sleep 2005, 28:395-409.
39. Le-Niculescu H., Patel S.D., Bhat M., Kuczenski R., Faraone S.V., Tsuang M.T., McMahon F.J., Schork N.J., Nurnberger J.I., Niculescu A.B. Convergent functional genomics of genome-wide association data for bipolar disorder: comprehensive identification of candidate genes, pathways and mechanisms. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2009, 150B:155-181.
40. Lee C.-Y., Fu W.-M., Chen C.-C., Su M.-J., Liou H.-H. Lamotrigine inhibits postsynaptic AMPA receptor and glutamate release in the dentate gyrus. Epilepsia 2008, 49:888-897.
41. Mai L., Jope R.S., Li X. BDNF-mediated signal transduction is modulated by GSK3β and mood stabilizing agents. J. Neurochem. 2002, 82:75-83.
42. Mansour H.A., Wood J., Logue T., Chowdari K.V., Dayal M., Kupfer D.J., Monk T.H., Devlin B., Nimgaonkar V.L. Association study of eight circadian genes with bipolar I disorder, schizoaffective disorder and schizophrenia. Genes Brain Behav. 2006, 5:150-157.
43. Masumoto K.H., Ukai-Tadenuma M., Kasukawa T., Nagano M., Uno K.D., Tsujino K., Horikawa K., Shigeyoshi Y., Ueda H.R. Acute induction of Eya3 by late-night light stimulation triggers TSHβ expression in photoperiodism. Curr. Biol. 2010, 20:2199-2206.
44. Mazefsky C.A., Folstein S.E., Lainhart J.E. Overrepresentation of mood and anxiety disorders in adults with autism and their first-degree relatives: what does it mean?. Autism Res. 2008, 1:193-197.
45. McNulty S.E., Barrett R.M., Vogel-Ciernia A., Malvaez M., Hernandez N., Davatolhagh M.F., Matheos D.P., Schiffman A., Wood M.A. Differential roles for Nr4a1 and Nr4a2 in object location vs. object recognition long-term memory. Learn. Mem. 2012, 19:588-592.
46. Mertens J., Wang Q.-W., Kim Y., Yu D.X., Pham S., Yang B., Zheng Y., Diffenderfer K.E., Zhang J., Soltani S., et al. Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder. Nature 2015, 527:95-99. Pharmacogenomics of Bipolar Disorder Study.
47. Michiels S., Koscielny S., Hill C. Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet 2005, 365:488-492.
48. Mieda M., Sakurai T. Bmal1 in the nervous system is essential for normal adaptation of circadian locomotor activity and food intake to periodic feeding. J. Neurosci. 2011, 31:15391-15396.
49. Miyawaki Y., Uchida H., Yamashita O., Sato M.A., Morito Y., Tanabe H.C., Sadato N., Kamitani Y. Visual image reconstruction from human brain activity using a combination of multiscale local image decoders. Neuron 2008, 60:915-929.
50. Nakajima H., Koizumi K. Family with sequence similarity 107: a family of stress responsive small proteins with diverse functions in cancer and the nervous system (Review). Biomed. Rep. 2014, 2:321-325.
51. Nakatani N., Hattori E., Ohnishi T., Dean B., Iwayama Y., Matsumoto I., Kato T., Osumi N., Higuchi T., Niwa S., Yoshikawa T. Genome-wide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: relevance to neuronal network perturbation. Hum. Mol. Genet. 2006, 15:1949-1962.
52. Naylor E., Bergmann B.M., Krauski K., Zee P.C., Takahashi J.S., Vitaterna M.H., Turek F.W. The circadian clock mutation alters sleep homeostasis in the mouse. J. Neurosci. 2000, 20:8138-8143.
53. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron 2002, 34:13-25.
54. Nievergelt C.M., Kripke D.F., Barrett T.B., Burg E., Remick R.A., Sadovnick A.D., McElroy S.L., Keck P.E., Schork N.J., Kelsoe J.R. Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2006, 141B:234-241.
55. Nurnberger J.I., Koller D.L., Jung J., Edenberg H.J., Foroud T., Guella I., Vawter M.P., Kelsoe J.R. Identification of pathways for bipolar disorder: a meta-analysis. JAMA Psychiatry 2014, 71:657-664. Psychiatric Genomics Consortium Bipolar Group.
56. O'Neill J.S., Maywood E.S., Chesham J.E., Takahashi J.S., Hastings M.H. cAMP-dependent signaling as a core component of the mammalian circadian pacemaker. Science 2008, 320:949-953.
57. Okuma T., Inanaga K., Otsuki S., Sarai K., Takahashi R., Hazama H., Mori A., Watanabe M. Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: a double-blind controlled study. Psychopharmacology (Berl.) 1979, 66:211-217.
58. Prickaerts J., Moechars D., Cryns K., Lenaerts I., van Craenendonck H., Goris I., Daneels G., Bouwknecht J.A., Steckler T. Transgenic mice overexpressing glycogen synthase kinase 3β: a putative model of hyperactivity and mania. J. Neurosci. 2006, 26:9022-9029.
59. Purcell S.M., Moran J.L., Fromer M., Ruderfer D., Solovieff N., Roussos P., O'Dushlaine C., Chambert K., Bergen S.E., Kähler A., et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 2014, 506:185-190.
60. Reis-Filho J.S., Pusztai L. Gene expression profiling in breast cancer: classification, prognostication, and prediction. Lancet 2011, 378:1812-1823.
61. Robison A.J. Emerging role of CaMKII in neuropsychiatric disease. Trends Neurosci. 2014, 37:653-662.
62. Salas T.R., Reddy S.A., Clifford J.L., Davis R.J., Kikuchi A., Lippman S.M., Menter D.G. Alleviating the suppression of glycogen synthase kinase-3β by Akt leads to the phosphorylation of cAMP-response element-binding protein and its transactivation in intact cell nuclei. J. Biol. Chem. 2003, 278:41338-41346.
63. Samuels B.A., Hen R. Neurogenesis and affective disorders. Eur. J. Neurosci. 2011, 33:1152-1159.
64. Sano H., Nagai Y., Miyakawa T., Shigemoto R., Yokoi M. Increased social interaction in mice deficient of the striatal medium spiny neuron-specific phosphodiesterase 10A2. J. Neurochem. 2008, 105:546-556.
65. Satoh J., Tabunoki H. Comprehensive analysis of human microRNA target networks. BioData Min. 2011, 4:17.
66. Shi J., Wittke-Thompson J.K., Badner J.A., Hattori E., Potash J.B., Willour V.L., McMahon F.J., Gershon E.S., Liu C. Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2008, 147B:1047-1055.
67. Shin R., Kobayashi K., Hagihara H., Kogan J.H., Miyake S., Tajinda K., Walton N.M., Gross A.K., Heusner C.L., Chen Q., et al. The immature dentate gyrus represents a shared phenotype of mouse models of epilepsy and psychiatric disease. Bipolar Disord. 2013, 15:405-421.
68. Siuciak J.A., McCarthy S.A., Chapin D.S., Fujiwara R.A., James L.C., Williams R.D., Stock J.L., McNeish J.D., Strick C.A., Menniti F.S., Schmidt C.J. Genetic deletion of the striatum-enriched phosphodiesterase PDE10A: evidence for altered striatal function. Neuropharmacology 2006, 51:374-385.
69. Soderling S.H., Beavo J.A. Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions. Curr. Opin. Cell Biol. 2000, 12:174-179.
70. Takao K., Miyakawa T. Genomic responses in mouse models greatly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. USA 2015, 112:1167-1172.
71. Takao K., Kobayashi K., Hagihara H., Ohira K., Shoji H., Hattori S., Koshimizu H., Umemori J., Toyama K., Nakamura H.K., et al. Deficiency of schnurri-2, an MHC enhancer binding protein, induces mild chronic inflammation in the brain and confers molecular, neuronal, and behavioral phenotypes related to schizophrenia. Neuropsychopharmacology 2013, 38:1409-1425.
72. Tomita H., Ziegler M.E., Kim H.B., Evans S.J., Choudary P.V., Li J.Z., Meng F., Dai M., Myers R.M., Neal C.R., et al. G protein-linked signaling pathways in bipolar and major depressive disorders. Front. Genet. 2013, 4:297.
73. Valor L.M., Jancic D., Lujan R., Barco A. Ultrastructural and transcriptional profiling of neuropathological misregulation of CREB function. Cell Death Differ. 2010, 17:1636-1644.
74. VanElzakker M., Fevurly R.D., Breindel T., Spencer R.L. Environmental novelty is associated with a selective increase in Fos expression in the output elements of the hippocampal formation and the perirhinal cortex. Learn. Mem. 2008, 15:899-908.
75. Walton N.M., Zhou Y., Kogan J.H., Shin R., Webster M., Gross A.K., Heusner C.L., Chen Q., Miyake S., Tajinda K., et al. Detection of an immature dentate gyrus feature in human schizophrenia/bipolar patients. Transl. Psychiatry 2012, 2:e135.
76. Wayman C., Phillips S., Lunny C., Webb T., Fawcett L., Baxendale R., Burgess G. Phosphodiesterase 11 (PDE11) regulation of spermatozoa physiology. Int. J. Impot. Res. 2005, 17:216-223.
77. Weisler R.H., Keck P.E., Swann A.C., Cutler A.J., Ketter T.A., Kalali A.H. Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial. J. Clin. Psychiatry 2005, 66:323-330. SPD417 Study Group.
78. Whitfield C.W., Cziko A.-M., Robinson G.E. Gene expression profiles in the brain predict behavior in individual honey bees. Science 2003, 302:296-299.
79. Wolff E.A., Putnam F.W., Post R.M. Motor activity and affective illness. The relationship of amplitude and temporal distribution to changes in affective state. Arch. Gen. Psychiatry 1985, 42:288-294.
80. Wong S.K.-F. G protein selectivity is regulated by multiple intracellular regions of GPCRs. Neurosignals 2003, 12:1-12.
81. Xing G., Russell S., Hough C., O'Grady J., Zhang L., Yang S., Zhang L.-X., Post R. Decreased prefrontal CaMKII alpha mRNA in bipolar illness. Neuroreport 2002, 13:501-505.
82. Yamasaki N., Maekawa M., Kobayashi K., Kajii Y., Maeda J., Soma M., Takao K., Tanda K., Ohira K., Toyama K., et al. Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders. Mol. Brain 2008, 1:6.
83. Zhang X., Odom D.T., Koo S.-H., Conkright M.D., Canettieri G., Best J., Chen H., Jenner R., Herbolsheimer E., Jacobsen E., et al. Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc. Natl. Acad. Sci. USA 2005, 102:4459-4464.